Dr. Griffiths and her staff are the best in the business. Their care and professionalism are outstanding. If you’re looking for excellent eye care, look no further!
Nicole Baker Fulgham
Uveitis can affect people of any age, but certain health conditions and genetic factors raise the likelihood of developing it. Identifying these risk factors helps ensure the right people receive appropriate screening and monitoring.
Uveitis most often affects adults between the ages of 20 and 60, though it also occurs in children. It can develop in otherwise healthy people, but it is more likely in individuals who have underlying immune or inflammatory conditions. Because symptoms can sometimes be subtle, many cases go unnoticed until vision is affected.
The majority of uveitis cases in developed countries are noninfectious, meaning they are not caused by a virus or bacteria. Instead, they result from the immune system mistakenly attacking the eye's own tissues. Conditions associated with uveitis include sarcoidosis, Behcet disease, and Vogt-Koyanagi-Harada syndrome. In children, juvenile idiopathic arthritis is one of the most significant risk factors.
A genetic marker called HLA-B27 plays an important role in uveitis risk. People who carry this marker and also live with conditions such as ankylosing spondylitis or psoriatic arthritis face a meaningfully elevated risk of developing uveitis. HLA-B27-associated uveitis is recognized as one of the most common identifiable causes of noninfectious uveitis. Testing for this marker is often part of the diagnostic workup.
Some forms of uveitis are caused by infections, including syphilis, tuberculosis, and herpes viruses. These infectious types require specific antibiotic or antiviral treatment alongside anti-inflammatory therapy. Identifying an infectious cause is critical because using immune-suppressing medications alone when an infection is present can be harmful. A thorough evaluation helps distinguish infectious from noninfectious uveitis before treatment begins.
Uveitis symptoms vary depending on the type and location of inflammation. Some forms cause obvious discomfort right away, while others develop slowly with little or no pain. Knowing what to look for can mean the difference between early treatment and serious vision loss.
Regardless of type, uveitis commonly causes a recognizable set of symptoms that should prompt an eye evaluation.
Anterior uveitis tends to develop rapidly, often within a few days. It typically causes noticeable pain, significant redness, and strong light sensitivity. Some people also notice that the pupil in the affected eye appears smaller than usual. Because the symptoms are often obvious, people with anterior uveitis usually seek care quickly, which supports earlier treatment and better outcomes.
Posterior uveitis can be harder to detect early because it may develop gradually with no pain or redness at all. The first sign is often blurred vision or an increase in floaters. Because the damage occurs in the choroid and retina at the back of the eye, serious harm can develop before symptoms become obvious. This is why routine dilated eye exams are especially important for people with known risk factors.
Some symptoms require immediate attention and should not be waited on. Go to a retina specialist or the nearest emergency room right away if you experience sudden eye pain, a rapid increase in floaters, flashes of light, a shadow or curtain across part of your vision, or sudden vision loss. Prompt treatment in these situations can be critical to preserving your sight.
Diagnosing uveitis requires a thorough eye examination combined with imaging tests and, often, blood work. The goal is to confirm the diagnosis, identify the type and severity of inflammation, and uncover any underlying cause that needs to be treated.
A retina specialist will begin with a detailed eye examination using a slit lamp, which is a specialized microscope that uses a narrow beam of light to examine the structures inside the eye in fine detail. The specialist looks for inflammatory cells in the fluid chambers of the eye, protein deposits on the inner cornea, and signs of retinal swelling or damage. A dilated exam allows a full view of the retina and choroid at the back of the eye.
Imaging plays an important role in understanding how far inflammation has spread and what structures are affected. Optical coherence tomography, or OCT, creates detailed cross-sectional images of the retina and can detect macular edema, which is swelling in the central retina. Fluorescein angiography uses a dye injected into a vein to reveal leaking or abnormal blood vessels. These tools help guide treatment decisions and track how well the eye responds over time.
Because uveitis is often linked to a condition affecting the whole body, blood tests and other laboratory work are frequently part of the evaluation. Testing may check for HLA-B27, markers of sarcoidosis, evidence of syphilis or tuberculosis, and other signs of autoimmune activity. Chest imaging may also be ordered. When an underlying systemic condition is identified, treating it alongside the eye inflammation leads to better results for both.
Treatment for uveitis depends on the type, location, and cause of inflammation. The goal is always to reduce swelling, protect vision, and address the underlying condition when one is present. A retina specialist will work with you to find the most effective and least burdensome approach for your situation.
For anterior uveitis, corticosteroid eye drops are usually the first treatment recommended. These drops work directly inside the eye to reduce inflammation. A dilating drop is often prescribed alongside them to relieve pain and prevent the iris from adhering to the lens, a complication known as a posterior synechiae. Treatment is typically tapered slowly over time rather than stopped all at once, which helps prevent rebound inflammation.
When inflammation affects the back of the eye or does not respond well to eye drops, a retina specialist may recommend a steroid injection or an implant that releases medication gradually. Ozurdex, a dexamethasone implant, is approved for noninfectious posterior uveitis and provides medication for three to four months. YUTIQ, a tiny implant containing fluocinolone acetonide, is approved for chronic noninfectious posterior uveitis and delivers sustained medication for up to 36 months. Retisert is a surgically implanted device that provides medication for a similar duration. These options can reduce the need for frequent drops or systemic medications in certain patients. Cases requiring these implants or complex injections are coordinated with or referred to the appropriate specialist.
For patients with noninfectious intermediate, posterior, or panuveitis who require stronger systemic treatment, Humira (adalimumab) is an FDA-approved biologic therapy. It works by blocking a protein called tumor necrosis factor-alpha, which plays a central role in driving inflammation. Humira is given as a self-administered injection under the skin, typically every two weeks. Multiple adalimumab biosimilars have also become available, expanding access to this class of treatment for eligible patients.
When corticosteroids alone are not enough, or when long-term steroid use creates unacceptable side effects, a retina specialist may recommend immunosuppressive medications. These drugs calm the overactive immune response responsible for chronic uveitis. Options used in practice include methotrexate, mycophenolate, azathioprine, and cyclosporine. Infliximab, another biologic agent, is also used in some cases. Regular blood monitoring is needed to watch for side effects while taking these medications.
When uveitis causes macular edema, which is swelling in the central retina, additional targeted treatment may be needed to preserve central vision. This may involve injections into the eye to reduce the swelling directly. Newer treatments targeting specific inflammatory pathways are being studied in clinical trials and may offer additional options in the future. Your care team will determine whether managing macular edema requires referral to a retina surgeon for specialized care.
Uveitis often requires ongoing care rather than a single course of treatment. Understanding what follow-up looks like and how to monitor your own health helps you stay ahead of complications.
At the start of treatment, office visits are often frequent so that a retina specialist can track inflammation levels closely and adjust medications as needed. Eye drops may need to be used multiple times a day early on and then slowly reduced. If injections or implants are part of the plan, the specialist will monitor eye pressure and watch for the development of cataracts, both of which can occur with long-term steroid use.
The course of uveitis varies greatly from person to person. Some patients experience a single episode that resolves fully with a short round of treatment. Others face recurrent flares or chronic inflammation requiring years of management. With early detection and consistent care, most patients are able to preserve meaningful vision. However, complications such as glaucoma, cataracts, and retinal scarring can still develop and require prompt attention when they arise.
Wearing sunglasses outdoors can help manage light sensitivity during active flares. If you smoke, stopping may reduce the likelihood of worsening inflammation. Keeping a record of your symptoms, including when flares occur and what circumstances surrounded them, gives your specialist valuable information at each visit. Do not stop any prescribed medications without first speaking with your retina specialist, as doing so can trigger a significant flare.
Uveitis frequently requires more than one type of specialist. A retina specialist manages the eye inflammation directly, while a rheumatologist or other physician may oversee the underlying systemic condition. Keeping all of your providers informed about your full treatment plan and any new symptoms ensures that your care is well coordinated. Prompt communication between your specialists can prevent gaps in treatment and support better long-term outcomes.
These answers address common questions about uveitis that go beyond the basics covered above, with a focus on practical decisions and situations you may encounter.
Stress is not a direct cause of uveitis, but it can affect immune function in ways that may trigger a flare in someone who already has an underlying autoimmune condition. Managing stress through healthy habits may support overall immune stability, but it is not a replacement for medical treatment. If you notice that flares seem to coincide with stressful periods, mention this to your retina specialist so it can be factored into your overall management plan.
No, they are very different conditions. Pink eye, or conjunctivitis, is inflammation of the thin outer membrane covering the white of the eye. Uveitis is inflammation that occurs inside the eye, affecting deeper structures such as the iris, ciliary body, choroid, and retina. Uveitis carries a far greater risk of serious vision loss. While both conditions can cause redness, uveitis also produces pain, light sensitivity, and vision changes that conjunctivitis typically does not. If you are unsure which condition you have, an eye exam will clarify the diagnosis quickly.
Yes, children can and do develop uveitis. Children with juvenile idiopathic arthritis face a particularly elevated risk. A challenging aspect of uveitis in children is that it may cause few or no obvious symptoms at first, making it easy to miss without regular screening. Routine eye exams are essential for children with known risk factors. If a child is flagged for uveitis screening, a retina specialist or uveitis specialist with pediatric experience should conduct a thorough evaluation.
Not necessarily. Many patients with uveitis are able to preserve good vision, especially when the condition is caught early and treated consistently. The risk of vision loss increases with delayed diagnosis, untreated flares, and the development of complications like glaucoma or macular edema. Staying current with your follow-up appointments and reporting new symptoms promptly gives you the best chance of protecting your sight over the long term.
Treatment length depends entirely on the type of uveitis you have. A single episode of acute anterior uveitis may resolve with a few weeks of eye drops. Recurrent or chronic forms often require months or years of treatment, which can include long-acting implants or immunosuppressive medications. Your retina specialist will reassess the treatment plan regularly based on how well your inflammation is controlled and whether complications have developed. The goal is always to use the lowest effective level of treatment for the shortest necessary period.
You should seek evaluation promptly at the first sign of uveitis symptoms, particularly eye pain, light sensitivity, redness, or new floaters. If you have an autoimmune or inflammatory condition already associated with uveitis risk, ask your primary doctor for a referral for a baseline eye exam even if you feel no symptoms. Emergency evaluation is needed immediately for sudden vision loss, a shadow or curtain across your vision, or a dramatic increase in floaters paired with flashes of light. These signs may indicate a serious complication that requires urgent care.
If you are experiencing symptoms of uveitis or have been told you are at risk, our team at NewView Eye Center is here to help you get answers and protect your vision. We provide thorough, personalized evaluations and work closely with our patients throughout Northern Virginia to ensure that inflammation is caught early and managed with care. We welcome you to contact us to schedule an appointment and take an important step toward long-term eye health.
Find more information about our doctors, services, and technology that keep your eyes healthy and your vision at its best.